Authors:
Abraham, E
Reinhart, K
Svoboda, P
Seibert, A
Olthoff, D
Dal Nogare, A
Postier, R
Hempelmann, G
Butler, T
Martin, E
Zwingelstein, C
Percell, S
Shu, V
Leighton, A
Creasey, AA
Citation: E. Abraham et al., Assessment of the safety of recombinant tissue factor pathway inhibitor inpatients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study, CRIT CARE M, 29(11), 2001, pp. 2081-2089
Authors:
Rueffert, H
Olthoff, D
Deutrich, C
Froster, UG
Citation: H. Rueffert et al., Determination of a positive malignant hyperthermia (MH) disposition without the in vitro contracture test in families carrying the RYR1 Arg614Cys mutation, CLIN GENET, 60(2), 2001, pp. 117-124
Authors:
Rueffert, H
Olthoff, D
Deutrich, C
Thamm, B
Froster, UG
Citation: H. Rueffert et al., Homozygous and heterozygous Arg614Cys mutations (1840C -> T) in the ryanodine receptor gene co-segregate with malignant hyperthermia susceptibility in a German family, BR J ANAEST, 87(2), 2001, pp. 240-245
Citation: L. Schaffranietz et al., Use of the sitting position in neurosurgery. Results of a 1998 survey in Germany, ANAESTHESIS, 49(4), 2000, pp. 269-274
Authors:
Apitzsch, H
Olthoff, D
Thieme, V
Wiegel, M
Bohne, V
Vetter, B
Citation: H. Apitzsch et al., Remifentanil and alfentanil. Sympatho-adrenergic effects during the early postoperative period in patients with cardiac risk, ANAESTHESIS, 48(5), 1999, pp. 301-309